Journal
EFORT OPEN REVIEWS
Volume 6, Issue 8, Pages 629-640Publisher
BRITISH EDITORIAL SOC BONE & JOINT SURGERY
DOI: 10.1302/2058-5241.6.200124
Keywords
comorbidity; hip arthroplasty; knee arthroplasty
Categories
Ask authors/readers for more resources
Comorbidity indices used in orthopaedic surgery were originally developed for non-orthopaedic patients and are now commonly used. With the increasing rate of hip and knee arthroplasty, understanding the impact of comorbid diseases on postoperative outcomes is crucial. Therefore, developing an updated and standardized approach for comorbidity assessment and reporting is essential.
Comorbidity indices currently used to estimate negative postoperative outcomes in orthopaedic surgery were originally developed among non-orthopaedic patient populations. While current indices were initially intended to predict short-term mortality, they have since been used for other purposes as well. As the rate of hip and knee arthroplasty steadily rises, understanding the magnitude of the effect of comorbid disease on postoperative outcomes has become increasingly more important. Currently, the ASA classification is the most commonly used comorbidity measure and is systematically recorded by the majority of national arthroplasty registries. Consideration should be given to developing an updated, standardized approach for comorbidity assessment and reporting in orthopaedic surgery, especially within the setting of elective hip and knee arthroplasty.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available